 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval1 Y3 D1 n0 \) p+ Z
$ V! `$ u; \/ I. a" C! O
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.; U1 v+ f3 {' d$ a2 w% A0 b' W r
, z: N$ W$ e$ z' D4 g: X
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007' R# z/ U( @- m) R6 k! j
0 T* p* r8 a9 E) o ^8 }+ p! f
0 X, F! Z9 s7 F+ k! s' s
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.: J1 x1 c, k3 ~8 T7 d
1 z* c9 u9 }5 Z" }8 c" S) `, _, ]
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
( l0 B3 x" H0 ~( P, @1 A
' H8 N A1 n! |2 h; u: {( OThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
1 G. }/ P/ Z. ?: Q( j1 r2 J/ B+ [8 b# {& ^) ]$ x# S! |
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.' R, W5 V% U8 w
- [' q2 r4 `7 w( z& tIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.6 S7 u( t* ]- S
# \9 | Z6 l# [+ X
"As a scientist, it's one of the highlights of my CAREER," Shan said.$ w; @( u" l: [1 x: ?5 p6 c# a
! R9 v7 Q- u2 E( ?0 u
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
9 i$ A/ E; i* e
/ N! d7 s3 Q% U5 A( a3 `" aIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
- x) B; j* s' ]9 Y B3 c. @& r5 G# E/ N4 e3 Z1 T5 G' J+ l
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
& l; |2 t7 N/ m# o! Z- K; z% k7 h4 {' s, q. H! Q' A' ^
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
/ Y2 S- ^ g, N" o5 [; O5 {' i. m. Z0 R0 v7 S; ~. b3 q) C+ o' @
' |6 I) u2 F8 b7 ]: Zhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
0 }: j& }& g. u+ Q# Y/ y- w ^
发表于 2015-2-28 19:45
